DAHUA-TECHNOLOGY
31.8.2022 14:46:35 CEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, officially released the Dahua DeepHub Pro Series at its online global launch. Equipped with ultra-low-latency writing, one-tap wireless screen sharing, built-in camera & microphone and other advanced AI functions, Dahua DeepHub delivers a flexible, multimedia approach to teaching and conferencing, providing participants with an immersive, interactive and content-rich experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220831005338/en/
Traditional methods of learning in classroom settings have several challenges, including poor interaction between students and teachers, and potentially poor visual clarity from some positions in the room. Dahua’s DeepHub interactive whiteboard is designed to provide a content-rich, interactive and stimulating learning experience in schools and colleges, consigning to history conventional whiteboards and other presenting platforms. (Photo: Business Wire)
“Dahua DeepHub combines Dahua's advantages in core technologies such as video, audio and high-definition video transmission to offer a complete range of smart interactive whiteboards. From entry-level Lite Series to high-end Pro Series, this product meets the growing digitalization and collaboration demands of both business and education customer groups in the modern-day IoT world,” said Josh Wang, Product Manager of Dahua DeepHub.
The online launch highlighted several features of Dahua DeepHub. For instance, it utilizes Zero Air Gap Technology on the screen to reduce parallax for clearer image display. Ink signal latency is also optimized, providing approximately 50 pages or 1,500 strokes of continuous writing.
To enhance visual output and operation, Dahua DeepHub utilizes powerful AI functions including Handwriting Recognition that can recognize intelligible handwritten texts and shapes, and Gesture Control to easily operate the device anywhere in the room. It can even automatically detect and focus on the current speaker for better interaction. Also, on-screen materials can be displayed onto other devices in the room and be edited in real-time through the Two-way Sharing function.
Dahua DeepHub also supports SIMS device management system, allowing IT personnel to fully grasp the operating status of the device. It has flagship smartphone-level chip equipped with 8 execution engine GPU to ensure image rendering capability, and an NPU that offers five tops computing power – another unprecedented feature in the industry.
Furthermore, it operates using a single Type C cable that can replace HDMI, audio and touchscreen cables, and can supply power to external devices. It supports fingerprint access control, AirPlay, Chromecast, Miracast, and Eshare wireless connections, as well as Android 11 and Windows 10 operating systems that can be flexibly switched.
The complete range of Dahua DeepHub Series marks a step forward towards Dahua's goal of empowering cities and enterprises with digital transformation through smart IoT technologies. With more models in the upcoming months, Dahua will continue to deliver better digital experience to global customers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005338/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom